Clinical Trials: National and International Perspective

Author(s)	Himanshu Goyal
Country	India
Abstract	Due to its expense and unpredictability, outsourcing has gained widespread acceptance in the pharmaceutical industry for the development and global trials of novel medications. Due to its sizable treatment-naive population, human resources, technical skills, adoption/amendment/implementation of rules/laws by regulatory bodies, and shifting economic environment, India would be the most sought-after country for contract pharma research and development. Nonetheless, there are still "miles to go" to meet the requirements to guarantee India's success. India is ambitious and optimistic about luring major pharmaceutical companies to conduct their clinical trials there despite all the obstacles.
Keywords	Clinical Trials, Drugs and Cosmetics Act, Clinical Trial Rules, ICMR Guidelines, International Perspective of Clinical Trials
Field	Sociology > Administration / Law / Management
Published In	Volume 5, Issue 2, March-April 2023
Published On	2023-03-23
Cite This	Clinical Trials: National and International Perspective - Himanshu Goyal - IJFMR Volume 5, Issue 2, March-April 2023. DOI 10.36948/ijfmr.2023.v05i02.1993
DOI	https://doi.org/10.36948/ijfmr.2023.v05i02.1993
Short DOI	https://doi.org/gr2km4

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research